ArticleScientific reports2026
Effects of vasopressin and antihyperkalemic treatments on hemodynamics, potassium concentration, and resuscitation success in a porcine hyperkalemic cardiac arrest model.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Vasopressin may improve blood flow during cardiopulmonary resuscitation (CPR) in hyperkalemic cardiac arrest. This could enhance the delivery of antihyperkalemic treatments and improve potassium-lowering effects and resuscitation outcomes. We assessed the effects of vasopressin and epinephrine, with and without antihyperkalemic treatments, on hemodynamics, laboratory parameters, and return of spontaneous circulation (ROSC) in a porcine model of hyperkalemic cardiac arrest. After inducing hyperkalemic cardiac arrest with potassium administration, 40 pigs were randomized into four groups: (1) epinephrine + saline placebo, (2) epinephrine + antihyperkalemic treatments, (3) vasopressin + saline placebo, and (4) vasopressin + antihyperkalemic treatments. Vasopressin (P = 0.004) and antihyperkalemic treatments (P = 0.042) significantly improved coronary perfusion pressure (CoPP) during CPR compared to epinephrine and saline placebo, respectively. Neither showed differences in potassium concentration during CPR compared to their respective controls. There was no significant interaction between vasopressor type and antihyperkalemic treatments for CoPP or potassium levels. Vasopressin and antihyperkalemic treatments significantly increased the odds of ROSC compared to epinephrine and saline placebo, respectively (both P = 0.017), with the highest ROSC rate in the combined treatment group. In conclusion, vasopressin improved ROSC through superior CoPP compared to epinephrine, without enhancing the potassium-lowering effects of antihyperkalemic treatments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.